G.PoulsenS
placebo), while higher weekly doses (3.04.5 mg) achieved reductions of up to 1.51% at 36 weeks
Our data on the stimulatory effect of ghrelin on GLP-1 gain support from a recent study by Gagnon et al
Dont suddenly stop taking your GLP-1
23 As shown in TABLE 2 , recommended nonpharmacologic interventions to reduce GI AEs include dietary modifications such as eating smaller, more frequent meals
Anholm C, Kumarathurai P, Pedersen LR, Samkani A, Walzem RL, Nielsen OW, Kristiansen OP, Fenger M, Madsbad S, Sajadieh A, et al: Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial